CWA Asset Management Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
SAM
GA
PFS
AIP
ONB
VFM
QCM
ERP
BIAS
CWA Asset Management Group's NVO Position: Q2 2026 in Review
CWA Asset Management Group increased its Novo Nordisk (NVO) stake by 0.76% in Q2 2026, buying an estimated $16.1K and bringing the position to 49,879 shares worth $2.39M. The position accounts for 0.07% of the portfolio, ranked #251.
CWA Asset Management Group first reported a position in NVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.04M in Q1 2025. 209 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- CWA Asset Management Group held 49,879 shares of Novo Nordisk worth $2.39M as of Q2 2026.
- CWA Asset Management Group bought 374 Novo Nordisk shares in Q2 2026, an estimated $16.1K.
- Novo Nordisk made up 0.07% of CWA Asset Management Group's portfolio in Q2 2026, its #251 holding.
- CWA Asset Management Group first reported a position in Novo Nordisk in Q4 2024 and has held it in 7 quarters since.
- CWA Asset Management Group's Novo Nordisk position peaked at $5.04M in Q1 2025.
- 209 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.